Literature DB >> 8300097

Urinary tract infection in men with AIDS.

A M De Pinho1, G S Lopes, C F Ramos-Filho, O da R Santos, M P De Oliveira, M Halpern, C A Gouvea, M Schechter.   

Abstract

OBJECTIVE--To investigate whether bacteriuria and, specifically, symptomatic urinary tract infection (UTI) occur with increased frequency in men with HIV infection. METHODS--In this cross-sectional study we investigated three groups of men, aged from 18 to 50 years. Group A was composed of patients with a diagnosis of AIDS; Group B, of patients without HIV infection, and group C of patients with asymptomatic HIV infection. Patients with any known predisposing factor for UTI were excluded from the study. A clean-catch midstream urine sample was collected from each patient on the first day of hospital admission (groups A and B) or during a visit to the outpatient clinic (group C). Bacteriuria was diagnosed when > or = 100,000 colony forming units/ml, urine were grown. RESULTS--There were 415 patients, 151 in group A, 170 in group B and 94 in group C. Bacteriuria was significantly more frequently in group A (20 cases, 13.3%) than in groups B (3 cases, 1.8%, p = 0.00007) and C (3 cases, 3.2%, p = 0.009). Ten cases of bacteriuria in group A (6.6%) were symptomatic while no case of symptomatic UTI was seen in groups B (p = 0.0004) and C (p = 0.008). The frequency of UTI in homosexual men with AIDS (7 cases, 6.7%) was not significantly different from that observed in men with AIDS who denied homosexuality (3 cases, 6.5%). E coli was the predominant pathogen associated with UTI. Although adequate response to a two-week course of antibiotics was observed in most cases, an in-hospital mortality rate of 20% was found among AIDS patients with symptomatic UTI. CONCLUSIONS--In the present study, the frequency of bacteriuria and symptomatic UTI was found to be increased in men with AIDS. E coli was the predominant pathogen in these cases. These data suggest that symptomatic UTI may represent a relevant cause of morbidity for men with AIDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300097      PMCID: PMC1195176          DOI: 10.1136/sti.70.1.30

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  20 in total

1.  Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies.

Authors:  G W Niedt; R A Schinella
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

2.  Autopsy findings in AIDS--a histopathological analysis of fifty cases.

Authors:  S Falk; H L Schmidts; H Müller; K Berger; M Schneider; W Schlote; E B Helm; W Stille; K Hübner; H J Stutte
Journal:  Klin Wochenschr       Date:  1987-07-15

3.  Prevalence of urinary tract infection in homosexual and heterosexual men.

Authors:  A P Wilson; S J Tovey; M W Adler; R N Grüneberg
Journal:  Genitourin Med       Date:  1986-06

4.  Urinary-tract infection in sexually active homosexual men.

Authors:  R C Barnes; R Daifuku; R E Roddy; W E Stamm
Journal:  Lancet       Date:  1986-01-25       Impact factor: 79.321

5.  Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus.

Authors:  M E García-Leoni; S Moreno; P Rodeñó; E Cercenado; T Vicente; E Bouza
Journal:  Arch Intern Med       Date:  1992-09

6.  Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

Authors:  J J Ballet; G Sulcebe; L J Couderc; F Danon; C Rabian; M Lathrop; J P Clauvel; M Seligmann
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

7.  Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome.

Authors:  I R Katz; S E Krown; B Safai; H F Oettgen; M K Hoffmann
Journal:  Clin Immunol Immunopathol       Date:  1986-06

8.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

9.  Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells.

Authors:  C Svanborg-Edén; A M Svennerholm
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

10.  Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome.

Authors:  E Whimbey; J W Gold; B Polsky; J Dryjanski; C Hawkins; A Blevins; P Brannon; T E Kiehn; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

View more
  7 in total

1.  HIV status is an independent risk factor for reporting lower urinary tract symptoms.

Authors:  Benjamin N Breyer; Stephen K Van den Eeden; Michael A Horberg; Michael L Eisenberg; Donna Y Deng; James F Smith; Alan W Shindel
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

2.  Detection of bacteriuria among human immunodeficiency virus seropositive individuals in Osogbo, south-western Nigeria.

Authors:  O A Olowe; B B Ojo-Johnson; O B Makanjuola; R A Olowe; V O Mabayoje
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

3.  Urinary tract infections in male veterans with human immunodeficiency virus.

Authors:  Caitlin Eccles-Radtke; Thomas S Rector; Andrea Cutting; Dimitri M Drekonja
Journal:  Open Forum Infect Dis       Date:  2014-11-05       Impact factor: 3.835

4.  Factors associated with urinary tract infections among HIV-1 infected patients.

Authors:  Agata Skrzat-Klapaczyńska; Bartłomiej Matłosz; Agnieszka Bednarska; Marcin Paciorek; Ewa Firląg-Burkacka; Andrzej Horban; Justyna D Kowalska
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

5.  Urinary Tract Infection among Antiretroviral Therapy Users and Nonusers in Jimma University Specialized Hospital, Jimma, Ethiopia.

Authors:  Serkadis Debalke; Waqtola Cheneke; Haimanot Tassew; Mohammed Awol
Journal:  Int J Microbiol       Date:  2014-04-16

6.  Characteristics and predictors of death among hospitalized HIV-infected patients in a low HIV prevalence country: Bangladesh.

Authors:  Lubaba Shahrin; Daniel T Leung; Nashaba Matin; Mohammed Moshtaq Pervez; Tasnim Azim; Pradip Kumar Bardhan; James D Heffelfinger; Mohammod Jobayer Chisti
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

7.  Comment on Hardacker, C.T.; Baccellieri, A.; Mueller, E.R.; Brubaker, L.; Hutchins, G.; Zhang, J.L.Y.; Hebert-Beirne, J. Bladder Health Experiences, Perceptions and Knowledge of Sexual and Gender Minorities. Int. J. Environ. Res. Public Health 2019, 16, 3170.

Authors:  Joshua S Jue; Mahmoud Alameddine
Journal:  Int J Environ Res Public Health       Date:  2020-03-30       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.